COMMUNIQUÉS West-GlobeNewswire

Venus Concept Announces CEO Transition
09/09/2026
TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer [...]
Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026
CHICAGO and FORT WORTH, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for [...]
AdCare Hospital Expands Detox Services with New 12-Bed Unit, Helping More People Access Care in Worcester
09/09/2026
WORCESTER, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- For decades, AdCare Hospital has been a staple in the Worcester community, providing hospital-level detox services for people struggling with substance use disorders [...]
Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian
09/09/2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today congratulated [...]
Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
09/09/2026
WALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted [...]
Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting Ceremony
09/09/2026
WALNUT CREEK, Calif. and SHANGHAI, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (DHCG) marked the opening of its Shanghai office with a ribbon cutting ceremony celebrating Dark Horse Consulting China. [...]
Momenta Oral & Maxillofacial Surgery Accredited by AAAHC, Recognized as a Center of Excellence
09/09/2026
IRVING, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited Momenta Oral & Maxillofacial Surgery , a full scope oral and maxillofacial surgery [...]
Acentra Health Named a Pioneer in URAC’s Leaders in Performance Measurement Program for Case Management
09/09/2026
Recognition highlights Acentra Health’s commitment to improving healthcare quality through effective performance measurement MCLEAN, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health [...]
Becoming Independent and Santa Rosa Junior College Partner to Bring “BI Olympics” to Santa Rosa
09/09/2026
SANTA ROSA, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Becoming Independent , a nonprofit supporting adults with disabilities live meaningful and independent lives, will host the 2026 BI Olympics on Friday, October 2, [...]
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
09/09/2026
DENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is entering a potentially important new phase with fresh institutional capital, encouraging Phase 2a data and a [...]
Zelluna ASA – Extraordinary General Meeting held on September 9, 2026
09/09/2026
Oslo, September 9, 2026: Zelluna ASA held its extraordinary general meeting today September 9, 2026. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s [...]
Medicana Uses Robot-Assisted Technology to Perform Heart Surgery Through Small Ports
09/09/2026
Medicana Health Group ’s Prof. Suat Büket, MD explains how selected bypass and heart-valve procedures can be completed without dividing the breastbone while maintaining the same surgical objective Photo: Robotic heart [...]
BayCare Generates $13 Billion in Economic Impact Annually for Florida
09/09/2026
CLEARWATER, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- BayCare’s commitment to serving the health care needs of the growing West Central Florida region also means positive outcomes for Florida’s economy. A new report by [...]
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
09/09/2026
Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24 th Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), [...]
Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors
09/09/2026
SAN DIEGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Wellcome Leap (Leap), a U.S. nonprofit founded by the Wellcome Trust to accelerate breakthroughs in human health, today announced that John Young and Thomas Glanzmann have [...]
Quetzal Therapeutics Appoints Harindra R. Abeysinghe, Ph.D., as Chief Regulatory and Quality Officer
09/09/2026
CHICAGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare diseases, including hematologic malignancies, today announced the appointment of [...]
Fast Company Names Visory Health to Its 2026 Best Workplaces for Innovators List
09/09/2026
The company’s collaborative culture and commitment to empowering employees earned the prestigious recognition ESTERO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Visory Health , a top-three prescription discount card [...]
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux
09/09/2026
Nantes, le 9 septembre 2026 – 18h00 CEST – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnémo : OSE) (la « Société ») se félicite de l’annonce de son partenaire Veloxis Pharmaceuticals, Inc. relative au traitement [...]
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
09/09/2026
Nantes, France, September 9, 2026 – 6pm CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the “Company”) welcomes the announcement by its licensee Veloxis Pharmaceuticals, Inc. that the first patient [...]

Pages